Drug Manufacturers - General

58.44

0.78% 0.36

노보 노디스크 (NVO)

개요 뉴스 가격 이력 옵션 체인 NVO 왜 하락? 토론 예측 주식 분할 배당 이력

Novo Nordisk Adr 주식(NVO)의 최신 뉴스

Down 61%, Is Novo Nordisk Stock Worth Buying on the Dip? - The Motley Fool

NVO Stock Quote Price and Forecast - CNN

European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading - marketscreener.com

Is Novo Nordisk Stock a Buy After its Collapse? - Morningstar

Eli Lilly and Novo Nordisk: Obesity Drug Coverage in Medicare Not a Straight Path - Morningstar

Is Novo Nordisk (NVO) the Best ADR Stock to Buy According to Hedge Funds? - Insider Monkey

Novo Nordisk’s $2B deal for obesity drug a strategic game-changer for US pharmaceutical market - Yahoo Finance

Why Novo Nordisk Stock Dipped on Thursday - Yahoo Finance

Novo Nordis Share Price | NYSE: NVO Stock - Investing.com UK

NOVO_B Stock Price and Chart — OMXCOP:NOVO_B - TradingView

INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Lawsuit Against Novo Nordisk A/SNVO - Finansavisen

Novo Nordisk shares plunge after obesity drug trial - The Irish Independent

Novo Nordisk AS (NVO) Stock Price, Trades & News - GuruFocus.com

Novo Nordisk A/S Sponsored ADR Class B to Host Earnings Call - ACCESS Newswire

META_TITLE_QUOTE - Yahoo Finance

Repare Surprises On Earnings; California Resources Falls Short - Evrim Ağacı

Why weight-loss drugs are the top target of Medicare price negotiations - Equities News

ABBV

$172.16

0.31%

NVS

$111.18

0.00%

JNJ

$157.70

0.22%

MRK

$77.59

0.17%

AMGN

$275.29

2.48%

야후에서 열기 | 구글에서 열기 | 핀비즈에서 열기 | MarketWatch에서 열기 | EDGAR에서 열기 | 로이터에서 공개